GALDIERO, MARIA ROSARIA
 Distribuzione geografica
Continente #
AS - Asia 4.054
NA - Nord America 3.362
EU - Europa 2.623
SA - Sud America 496
AF - Africa 143
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.688
Nazione #
US - Stati Uniti d'America 3.221
SG - Singapore 1.740
RU - Federazione Russa 1.289
VN - Vietnam 809
CN - Cina 765
IT - Italia 515
BR - Brasile 391
HK - Hong Kong 294
DE - Germania 201
FR - Francia 156
FI - Finlandia 111
IN - India 89
CA - Canada 76
GB - Regno Unito 74
IE - Irlanda 70
JP - Giappone 68
BD - Bangladesh 65
CI - Costa d'Avorio 61
NL - Olanda 49
MX - Messico 41
AR - Argentina 39
SE - Svezia 36
KR - Corea 35
PL - Polonia 31
ES - Italia 27
PH - Filippine 24
ZA - Sudafrica 23
IQ - Iraq 20
PK - Pakistan 18
TH - Thailandia 18
TR - Turchia 17
EC - Ecuador 16
VE - Venezuela 15
ID - Indonesia 13
AT - Austria 12
UA - Ucraina 12
EG - Egitto 9
TW - Taiwan 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
LT - Lituania 8
MA - Marocco 8
CO - Colombia 7
KE - Kenya 7
PE - Perù 7
SA - Arabia Saudita 7
TN - Tunisia 7
BE - Belgio 6
DZ - Algeria 6
PY - Paraguay 6
OM - Oman 5
RO - Romania 5
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
IL - Israele 4
JO - Giordania 4
KW - Kuwait 4
NP - Nepal 4
AM - Armenia 3
CR - Costa Rica 3
GA - Gabon 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SN - Senegal 3
UY - Uruguay 3
AU - Australia 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
CY - Cipro 2
DK - Danimarca 2
GP - Guadalupe 2
GY - Guiana 2
IR - Iran 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MK - Macedonia 2
NA - Namibia 2
NR - Nauru 2
PA - Panama 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TZ - Tanzania 2
UG - Uganda 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
AW - Aruba 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
Totale 10.667
Città #
Singapore 864
San Jose 561
Ashburn 345
Moscow 293
Hong Kong 286
Ho Chi Minh City 240
Chandler 233
Beijing 206
Hanoi 172
Santa Clara 141
Naples 112
Hefei 109
The Dalles 103
Los Angeles 88
Lauterbourg 84
Munich 78
Napoli 65
Millbury 64
Dong Ket 60
Tokyo 58
Boston 57
Nanjing 56
New York 50
Seattle 47
São Paulo 45
Des Moines 43
Redondo Beach 43
Lawrence 41
Buffalo 40
Council Bluffs 40
Princeton 40
Turku 40
Dallas 39
Helsinki 38
Rome 38
Amsterdam 33
Da Nang 32
Wilmington 32
Frankfurt am Main 30
Chicago 27
Haiphong 26
Montreal 24
Orem 24
Pune 23
Mexico City 21
Atlanta 20
Chennai 19
Denver 19
Houston 19
Seoul 19
Warsaw 19
Brooklyn 18
Dublin 17
Nuremberg 16
London 15
Falls Church 14
Hải Dương 14
Ottawa 14
Toronto 14
Curitiba 13
Guangzhou 13
Kochi 13
Poplar 13
Redwood City 13
Stockholm 13
Tianjin 13
Hebei 12
Manchester 12
Lappeenranta 11
Bangkok 10
Changsha 10
Dhaka 10
Fairfield 10
Falkenstein 10
Ankara 9
Biên Hòa 9
Düsseldorf 9
Johannesburg 9
Menlo Park 9
Nanchang 9
Jacksonville 8
Phoenix 8
Shanghai 8
Shenyang 8
Thái Bình 8
Angri 7
Boardman 7
Lahore 7
Quezon City 7
Quận Bình Thạnh 7
Salerno 7
San Francisco 7
Vienna 7
Woodbridge 7
Belo Horizonte 6
Bắc Giang 6
Bắc Ninh 6
Eboli 6
Jiaxing 6
Madrid 6
Totale 5.697
Nome #
Innate Immune Cells in Melanoma: Implications for Immunotherapy 187
Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and N-Acylethanolamines in Patients with Mastocytosis 182
Combating Actions of Green 2D-Materials on Gram Positive and Negative Bacteria and Enveloped Viruses 175
Immunosuppressive therapy with rituximab in common variable immunodeficiency 172
SARS-CoV-2 Spike Protein Activates Human Lung Macrophages 169
Hereditary angioedema attack: what happens to vasoactive mediators? 164
Neutrophil exhaustion and impaired functionality in psoriatic arthritis patients 162
Lipopolysaccharide-Elicited TSLPR Expression Enriches a Functionally Discrete Subset of Human CD14(+) CD1c(+) Monocytes 160
VEGF-A in cardiomyocytes and heart diseases 158
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients 156
Secreted phospholipases A2 in hereditary angioedema with C1-inhibitor deficiency 155
Mast cells have a protumorigenic role in human thyroid cancer. 154
Potential involvement of neutrophils in human thyroid cancer 153
Cardiotoxicity of immune checkpoint inhibitors 151
Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue 149
Epigenetics: an Opportunity to Shape Innate and Adaptive Immune Responses 147
Anaplastic Thyroid Cancer Cells Induce the Release of Mitochondrial Extracellular DNA Traps by Viable Neutrophils 145
Macrophage-polarizing stimuli differentially modulate the inflammatory profile induced by the secreted phospholipase A2 group IA in human lung macrophages. 144
“La diagnostica molecolare (CRD) nel laboratorio di allergologia: valutazione di allergeni ricombinanti in pazienti con allergie agli inalanti”. 142
Size-based effects of anthropogenic ultrafine particles on activation of human lung macrophages 141
Vascular endothelial growth factors and angiopoietins as new players in mastocytosis. (VARRICCHI AUTORE CORRISPONDENTE) 138
The human heart can be both the site and the target of anaphylactic reactions. 135
Recombinant allergens in the diagnosis of pollen-allergic patients: comparison with natural allergens extracts 133
PD-L1+ neutrophils as novel biomarkers for stage IV melanoma patients treated with nivolumab 132
How can we manage the cardiac toxicity of immune checkpoint inhibitors? 132
LOFFREDO and GALDIERO are CO-FIRST AUTHORS. Eosinophils: The unsung heroes in cancer? 131
Group V Secreted Phospholipase A2 Induces the Release of Proangiogenic and Antiangiogenic Factors by Human Neutrophils 130
Prostaglandin D2 receptor antagonists in allergic disorders: safety, efficacy and future perspectives 130
IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors. (VARRICCHI ULTIMO AUTORE E AUTORE CORRISPONDENTE) 128
Human cardiac mast cells in anaphylaxis 127
Innate effector cells in angiogenesis and lymphangiogenesis 126
GM-CSF and IL-3 Modulate Human Monocyte TNF-α Production and Renewal in In Vitro Models of Trained Immunity 125
Physiological Roles of Mast Cells: Collegium Internationale Allergologicum Update 2019 124
Role of Inflammation in Benign Salivary Gland Tumor Etiopathogenesis: An Evaluation through the Blood Inflammatory Biomarkers 123
Human Lung-Resident Macrophages Express and Are Targets of Thymic Stromal Lymphopoietin in the Tumor Microenvironment 123
Neutrophil extracellular traps and neutrophil-derived mediators as possible biomarkers in bronchial asthma 122
Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer 121
First Report of De Novo Nivolumab-Induced Oligoarthritis in a Young Man With Relapsing Classic Hodgkin Lymphoma 121
LOFFREDO is CO-FIRST AUTHOR. Are Mast Cells MASTers in Cancer? 120
Human cardiac mast cells in anaphylaxis 119
LPS-mediated neutrophil VEGF-A release is modulated by cannabinoid receptor activation. GALDIERO IS CO-LAST AUTHOR 119
The broad spectrum of cardiotoxicities from immunotherapies 118
Angiogenesis, lymphangiogenesis and atopic dermatitis. 118
Orofacial granulomatosis: Clinical and therapeutic features in an Italian cohort and review of the literature 117
The Interplay between the Immune and the Endocannabinoid Systems in Cancer 114
Neutrophil Extracellular Traps, Angiogenesis and Cancer 114
Roles of Immune Cells in Hereditary Angioedema 113
Innate immune modulation by GM-CSF and IL-3 in health and disease 112
Early Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review 112
Functional Modulation of Human Macrophages by Secreted Phospholipases A2: Implications in Cancer 112
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors 111
Roles of mast cells and their mediators in human thyroid carcinomas. 110
Neutrophil Extracellular Traps in Cancer 109
Controversial role of mast cells in skin cancers 107
Neutrophil extracellular traps and neutrophil-related mediators in human thyroid cancer 105
Tumor associated macrophages and neutrophils in cancer 104
Ca2+-Dependent Processes of Innate Immunity in IBD 103
Recombinant allergens in the diagnosis of pollen-allergic patients: comparison with natural allergens extracts. 101
Melanoma-derived soluble mediators modulate neutrophil biological properties and the release of neutrophil extracellular traps 99
PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer 96
Role of the RNA-binding protein tristetraprolin in glucocorticoid-mediated gene regulation 96
Neutrophils in innate and adaptive immunity 95
Differential activation of monocytes and PMNs in orofacial granulomatosis patients induced by bacterial and non-bacterial stimuli 95
Thymic stromal lymphopoietin (TSLP) is a substrate for tryptase in patients with mastocytosis 94
Pharmacovigilating cardiotoxicity of immune checkpoint inhibitors 92
GALDIERO is CO-FIRST AUTHOR. Phagocytes as Corrupted Policemen in Cancer-Related Inflammation 91
Mast cells play (a) protumorigenic roles in human thyroid cancer. 90
ROLES OF MAST CELLS AND THEIR MEDIATORS IN HUMAN THYROID CARCINOMAS 88
Mast Cells in Early Rheumatoid Arthritis 88
Macrophage plasticity and polarization in tissue repair and remodelling 87
Immune mediators as potential diagnostic tools for colorectal cancer: from experimental rationale to early clinical evidence 85
Mast cells and basophils in angiogenesis: bridging the gap between inflammation and tumors 84
CMTM4 as a new partner for IL-17 receptor: Adding a piece in the puzzle of IL17-driven diseases 82
Immune checkpoint inhibitors-induced autoimmunity: The impact of gender 81
Tumor-associated Macrophages in Cancer Growth and Progression 80
Cardiac Toxicity in Patients Treated With Immune Checkpoint Inhibitors: It Is Now Time for Cardio-Immuno-Oncology 80
Immune and inflammatory cells in thyroid cancer microenvironment 80
New insight in endocrine-related adverse events associated to immune checkpoint blockade 78
Cancer Inflammation and Cytokines 77
Autoimmune endocrine dysfunctions associated with cancer immunotherapies 77
Histamine as a mediator of cross-talk between human lung mast cells and macrophages 76
Roles of neutrophils in cancer growth and progression 76
Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors 75
Are Basophils and Mast Cells Masters in HIV Infection? 73
The immune network in thyroid cancer 67
The immune landscape of thyroid cancer in the context of immune checkpoint inhibition 66
Occurrence and significance of tumor-Associated neutrophils in patients with colorectal cancer 65
Gender dimorphism in IgA subclasses in T2-high asthma 65
Hypersensitivity reactions to antineoplastic drugs. I. General aspects,Reazioni di ipersensibilit{\`a} a farmaci antineoplastici. I. aspetti generali 63
Cardiac Toxicity of Immune Checkpoint Inhibitors: Cardio-Oncology Meets Immunology 62
Editorial: Extracellular traps in cancer immunity and immunotherapy 60
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin 59
Macrophage Plasticity and Polarization: Relevance to Biomaterials 56
Molecular targets of tyrosine kinase inhibitors in thyroid cancer 54
Tumor associated macrophages and neutrophils in tumor progression. 53
Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer 53
Novel actors on the stage of cardiac dysfunction induced by anti-PD1 oncological treatments 52
The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity 48
Reazione da ipersensibilità a farmaci. Parte I. Manifestazioni cutanee. 46
Polarized activation of macrophages 45
Totale 10.834
Categoria #
all - tutte 35.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.514


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022452 15 16 7 12 5 11 8 30 63 26 99 160
2022/2023576 83 36 34 28 92 66 7 67 85 34 34 10
2023/2024583 13 60 53 35 38 99 20 131 9 8 80 37
2024/20252.898 143 126 16 46 47 217 309 172 160 272 1.077 313
2025/20265.635 624 341 595 606 1.020 206 689 262 668 348 150 126
2026/202746 46 0 0 0 0 0 0 0 0 0 0 0
Totale 10.887